The invention discloses a Chinese herbal
medicine in the treatment of sequels of
stroke and hemiplegia. The active pharmaceutical ingredient and weight ratios are demonstrated as follows:
ground beetle 3-10g,
astragalus 9-40g,
codonopsis pilosula extract 10-30g,
leonurus japonicus 9-30g, danshen root 9-15g,
cyathula root 5-10g, peach kernel 5-10g, Jiang Chong 10-20g, safflower 5-9g, rhizoma ligustici wallichii 5-15g,
scorpion 3-9g,
lumbricus 5-10g, red peony root 6-12g, poria cocos 5-15g, chinese starjasmine stem 6-12g,
stephania root 5-15g,
coix seed 9-30g, crab apple 9-12g,
eucommia bark 6-15g, combined spicebush root 5-10g, largehead atractylodes
rhizome 6-15g, oriental waterplantain
rhizome 6-15g, milettia reticulata 10-20g, gambir
plant 5-12g,
angelica sinensis 5-15g, turmeric
rhizome 5-9g,
cassia twig 3-9g, mulberry
twig 10-20g, chinese
clematis root 6-10g. That the sequels of
stroke and hemiplegia are difficult to cure is because that
muscle and joints are blocked by
phlegm and
blood stasis, which is caused by the deficiency of Qi. The prescription based on the
pathogenesis, by righting and supporting the healthy energy, activating
blood circulation to dissipate
blood stasis, reducing
phlegm and adjusting the balance of
Yin and Yang, removes the causes of the illness and the
total efficiency for the prescription is more than 98%.